Lack of CCR7 expression is rate limiting for lymphatic spread of pancreatic ductal adenocarcinoma
International Journal of Cancer, 05/04/2012Sperveslage J et al.
The study revealed strong evidence that lack of CCR7 impairs the metastatic potential of pancreatic ductal adenocarcinoma (PDAC). Lymph vessel invasion by CCR7 expressing PDAC cells may be additionally enhanced by upregulation of CCL21 in tumor–associated lymph vessels, representing a previously unknown factor of lymphatic spread.
MDLinx connects healthcare professionals and patients to tomorrow's important medical news, while providing the pharmaceutical and healthcare industries with highly targeted interactive marketing, education, content, and medical research solutions.